About Us
News
Products
Technolongy Platform
Investors
Contact Us
中文
EN
NEWS
Business Milestones
Patents
ALL
無列表圖
Patents
04.21
2021
TAHO's TAH9922 Atomoxetine oral solution product patent obtained a US patent license.
無列表圖
Patents
11.29
2017
TAHO obtained U.S. patent approval for TAH9901 methylphenidate transdermal patch, a transdermal ADHD treatment for pediatric ADHD.
無列表圖
Patents
09.01
2017
TAHO obtained U.S. patent approval for TAH9922 Atomoxetine oral solution, a child friendly ADHD mediation.
中文
EN
About Us
News
Products
Technolongy Platform
Investors
Contact Us
ADD
3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
TEL
+886-2-2659-8515
MAIL
info@tahopharma.com
© 2023 TAHO Pharmaceuticals Ltd. All rights reserved.
Design ibest
Verification
Click the numbers in sequence.
Change
